Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-20-000879
Filing Date
2020-07-22
Accepted
2020-07-22 16:05:46
Documents
1
Period of Report
2020-07-20

Document Format Files

Seq Description Document Type Size
1 e619799_4-vitt.html 4  
1 e619799_4-vitt.xml 4 5657
  Complete submission text file 0001193805-20-000879.txt   7052
Mailing Address AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152
Business Address AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152 49 89 250079460
IMMUNIC, INC. (Issuer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address IMMUNIC AG AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152
Business Address
Vitt Daniel (Reporting) CIK: 0001773673 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36201 | Film No.: 201041568